on SphingoTec GmbH
SphingoTec to Engage at Major 2026 Conferences
SphingoTec GmbH, based in Hennigsdorf, Germany, announces its participation in leading diagnostics and critical care medicine conferences throughout 2026. The company aims to advance biomarker-driven solutions for more precise clinical decisions in acute care.
Significant engagements include DGAI in Kassel and Kongress für Nephrologie in Leipzig. A noteworthy presence at ESICM Lives in Lisbon will feature a symposium co-hosted with Boditech. Additionally, new data on penKid will be showcased, focusing on sepsis diagnostics.
During ASN Kidney Week in Denver, penKid will be the focal point in poster sessions. At Medica in Düsseldorf, the emphasis will be on expanding the international industry network. In December, SphingoTec will engage at DIVI in Hamburg.
CEO Deborah Bergmann highlights these events as vital for collaboration aimed at translating biomarker innovations into clinical value.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all SphingoTec GmbH news